HTRA2 and coronary artery disorder: Growing evidence indicates that HtrA2, a pro-apoptotic protein, is associated with myocardial reperfusion injury [14,15,16,17,18,26] and that targeted anti-apoptotic treatments may improve clinical outcomes in patients with ischemic heart disease [27].